These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 38693104)

  • 1. Modulating extracellular matrix stiffness: a strategic approach to boost cancer immunotherapy.
    Mai Z; Lin Y; Lin P; Zhao X; Cui L
    Cell Death Dis; 2024 May; 15(5):307. PubMed ID: 38693104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk between T lymphocyte and extracellular matrix in tumor microenvironment.
    Lv D; Fei Y; Chen H; Wang J; Han W; Cui B; Feng Y; Zhang P; Chen J
    Front Immunol; 2024; 15():1340702. PubMed ID: 38690275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular matrix stiffness and tumor-associated macrophage polarization: new fields affecting immune exclusion.
    Yu KX; Yuan WJ; Wang HZ; Li YX
    Cancer Immunol Immunother; 2024 May; 73(6):115. PubMed ID: 38693304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor matrix remodeling and novel immunotherapies: the promise of matrix-derived immune biomarkers.
    Mushtaq MU; Papadas A; Pagenkopf A; Flietner E; Morrow Z; Chaudhary SG; Asimakopoulos F
    J Immunother Cancer; 2018 Jul; 6(1):65. PubMed ID: 29970158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomaterials to regulate tumor extracellular matrix in immunotherapy.
    Zhang Y; Dong X; Zhang Y; Chen Z; Zhou G; Chen N; Shen W; Yang K; Pei P
    J Control Release; 2024 Dec; 376():149-166. PubMed ID: 39389365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The key role of matrix stiffness in colorectal cancer immunotherapy: mechanisms and therapeutic strategies.
    Chen E; Zeng Z; Zhou W
    Biochim Biophys Acta Rev Cancer; 2024 Nov; 1879(6):189198. PubMed ID: 39413857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breaking Physical Barrier of Fibrotic Breast Cancer for Photodynamic Immunotherapy by Remodeling Tumor Extracellular Matrix and Reprogramming Cancer-Associated Fibroblasts.
    Qiu ZW; Zhong YT; Lu ZM; Yan N; Kong RJ; Huang JQ; Li ZF; Nie JM; Li R; Cheng H
    ACS Nano; 2024 Apr; 18(13):9713-9735. PubMed ID: 38507590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The extracellular matrix in solid tumor immunotherapy.
    Cho Y; Doh J
    Trends Immunol; 2024 Sep; 45(9):705-714. PubMed ID: 39164157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological role of matrix stiffness in tumor growth and treatment.
    Deng B; Zhao Z; Kong W; Han C; Shen X; Zhou C
    J Transl Med; 2022 Nov; 20(1):540. PubMed ID: 36419159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy.
    Jiang Y; Zhang H; Wang J; Liu Y; Luo T; Hua H
    J Hematol Oncol; 2022 Mar; 15(1):34. PubMed ID: 35331296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of tumor immunity and immunotherapy by the tumor collagen extracellular matrix.
    Flies DB; Langermann S; Jensen C; Karsdal MA; Willumsen N
    Front Immunol; 2023; 14():1199513. PubMed ID: 37662958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Interplay between Extracellular Matrix Remodeling and Cancer Therapeutics.
    Prakash J; Shaked Y
    Cancer Discov; 2024 Aug; 14(8):1375-1388. PubMed ID: 39091205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the matrix: collagen modifications in tumors and their implications for immunotherapy.
    Borst R; Meyaard L; Pascoal Ramos MI
    J Transl Med; 2024 Apr; 22(1):382. PubMed ID: 38659022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments.
    Yuan Z; Li Y; Zhang S; Wang X; Dou H; Yu X; Zhang Z; Yang S; Xiao M
    Mol Cancer; 2023 Mar; 22(1):48. PubMed ID: 36906534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of Extracellular Matrix Enhances Oncolytic Adenovirus Immunotherapy in Glioblastoma.
    Kiyokawa J; Kawamura Y; Ghouse SM; Acar S; Barçın E; Martínez-Quintanilla J; Martuza RL; Alemany R; Rabkin SD; Shah K; Wakimoto H
    Clin Cancer Res; 2021 Feb; 27(3):889-902. PubMed ID: 33257429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of matrix stiffness in cancer stromal cell fate and targeting therapeutic strategies.
    Wei J; Yao J; Yan M; Xie Y; Liu P; Mao Y; Li X
    Acta Biomater; 2022 Sep; 150():34-47. PubMed ID: 35948177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Herpes Simplex Virus-Type-1 (HSV-1) Oncolytic Immunotherapy on the Tumor Microenvironment.
    Uche IK; Kousoulas KG; Rider PJF
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34206677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of cell surface proteoglycans in cancer immunotherapy.
    Espinoza-Sánchez NA; Götte M
    Semin Cancer Biol; 2020 May; 62():48-67. PubMed ID: 31336150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of microenvironment on tumor immunotherapy.
    Zhang J; Shi Z; Xu X; Yu Z; Mi J
    FEBS J; 2019 Nov; 286(21):4160-4175. PubMed ID: 31365790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proinvasive extracellular matrix remodeling for tumor progression.
    Kaushik N; Kim S; Suh Y; Lee SJ
    Arch Pharm Res; 2019 Jan; 42(1):40-47. PubMed ID: 30515725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.